Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01331447 · ClinicalTrials.gov registry record · NA
Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
A NA study, sponsored by Roxane Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01331447 is a NA study that has completed, run by Roxane Laboratories. The registered enrollment target is 12 participants.
The verdict
NCT01331447, a NA study, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions
Interventions
- DRUG exemestane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2004-05 |
| Est. Completion | 2004-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01331447
The ClinicalTrials.gov registry entry for NCT01331447 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roxane Laboratories, which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which exemestane is the first listed.
NCT01331447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01331447 about?
NCT01331447 is a clinical study titled "Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions". The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions
What is the current status of trial NCT01331447?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2004-05. Estimated completion is 2004-05.
What interventions are being tested in trial NCT01331447?
The interventions under investigation include: exemestane (DRUG).
Who is sponsoring clinical trial NCT01331447?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.